Day traders' hip-hip-for-the-weekend lounge November 26-28, page-99

Totally agree. Over the past few years we've seen a bunch of genuine re rates in these biotechs eg IMU IBX ACW.

I thought BIT was going to join them when they made the HIV announcement but in all the COVID noise it got lost.

I'm watching for an entry for the SMSF as I think it will kick on. All the above have also been great DTers along the way as well.

Cheers

G